The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography
Open Access
- 2 February 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (2) , e0170871
Abstract
5-[18F]F-pyrazinamide (5-[18F]F-PZA), a radiotracer analog of the first-line tuberculosis drug pyrazinamide (PZA), was employed to determine the biodistribution of PZA using PET imaging and ex vivo analysis. 5-[18F]F-PZA was synthesized in 60 min using a halide exchange reaction. The overall decay-corrected yield of the reaction was 25% and average specific activity was 2.6 × 106 kBq (70 mCi)/μmol. The biodistribution of 5-[18F]F-PZA was examined in a pulmonary Mycobacterium tuberculosis mouse model, where rapid distribution of the tracer to the lung, heart, liver, kidney, muscle, and brain was observed. The concentration of 5-[18F]F-PZA was not significantly different between infected and uninfected lung tissue. Biochemical and microbiological studies revealed substantial differences between 5-F-PZA and PZA. 5-F-PZA was not a substrate for pyrazinamidase, the bacterial enzyme that activates PZA, and the minimum inhibitory concentration for 5-F-PZA against M. tuberculosis was more than 100-fold higher than that for PZA.Keywords
Funding Information
- National Institute of General Medical Sciences (GM102864)
- NIH Office of the Director (EB020539)
- NIH Office of the Director (OD006492)
This publication has 33 references indexed in Scilit:
- Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis InfectionPLOS ONE, 2013
- Noninvasive Determination of 2-[ 18 F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected MiceAntimicrobial Agents and Chemotherapy, 2012
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic LesionsThe Journal of Infectious Diseases, 2011
- Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-AnalysesAntimicrobial Agents and Chemotherapy, 2011
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosisScience, 2011
- Mutually Exclusive Genotypes for Pyrazinamide and 5-Chloropyrazinamide Resistance Reveal a Potential Resistance-Proofing StrategyAntimicrobial Agents and Chemotherapy, 2010
- Noninvasive Pulmonary [ 18 F]-2-Fluoro-Deoxy- d -Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug TreatmentAntimicrobial Agents and Chemotherapy, 2009
- Comparative Evaluation of Löwenstein-Jensen Proportion Method, BacT/ALERT 3D System, and Enzymatic Pyrazinamidase Assay for Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2007
- The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organismsMicrobiology, 1997
- Pyrazinoic Acid Esters with Broad Spectrum in Vitro Antimycobacterial ActivityJournal of Medicinal Chemistry, 1995